Many patients believe brand-name drugs are always safer than generics. But that’s a misunderstanding.Drug safety depends on regulation, not branding.What’s the Difference?An orig...
Treatment of type 1 diabetes (T1D) is entering a transformative era. The first immunotherapy approved to delay clinical onset—Teplizumab—has received FDA approval in the United S...